Fig. 6.
Longitudinal monitoring of acute (day 1 to day 3) and chronic (day 30 and day 60) changes after tMCAO. (a1-a6) Optical microscopic images from top-view before and after tMCAO. Yellow dashed square: side view from the microprism; blue dashed square: top-view; (b1-b6) Top-view vis-OCTA en face images before and after tMCAO. Blue arrow heads: vessel dilation (b2-b4); vessel constriction (b5-b6). Blue stars: reduced flow signal. Red arrows: bounded neovascularization. (c1-c6) Side-view vis-OCTA en face images before and after tMCAO. Green arrows: vessel dilation (c3-c4); vessel narrowing (c5-c6). Yellow stars: reduced flow signal. Red stars: overgrown neovascularization. (Black scale bar: 1mm; Red scale bar: 400 µm, Yellow scale bar: 200 µm)